middle.news
Entropy Neurodynamics Secures $1.73M Boost for Psychedelic Therapy Trials
9:56am on Thursday 5th of March, 2026 AEDT
•
Biotechnology
Read Story
Entropy Neurodynamics Secures $1.73M Boost for Psychedelic Therapy Trials
9:56am on Thursday 5th of March, 2026 AEDT
Key Points
Received $1.73 million R&D tax incentive refund for FY25
Funds support TRP-8803, an intravenous psilocin formulation
TRP-8803 aims to improve psychedelic therapy delivery
Refund equals 48.5% of eligible R&D expenditure
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ENTROPY NEURODYNAMICS (ASX:ENP)
OPEN ARTICLE